NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar
K212289 is the FDA 510(k) clearance record for NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar, a class II device, cleared for Neuronetics, Inc. on under FDA product code QCI (Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder). FDA's definition for product code QCI reads: "External device that uses magnetic fields to induce neural activity in the cerebral cortex to treat neurological and psychiatric disorders and conditions. It is not intended for applying or focusing magnetic fields towards brain areas...". FDA records list 15 510(k) clearances for Neuronetics, Inc., from to . As of , FDA records show no recalls naming K212289.
Clearance record
- Decision date
- Received
- (289 days to decision)
- Product code
- QCI Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder
- Regulation
- 21 CFR 882.5802
- Device class
- Class II
- Review panel
- Neurology
- Applicant
- Neuronetics, Inc. 3222 Phoenixville Pike, Malvern PA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QCI
Trailing 12 monthsFDA records hold no clearances under product code QCI in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
